TransMedics Group, Inc. (TMDX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
43/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 9 wins, 3 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
LoseTMDX / S&P -33.19% / 15.20% |
WinTMDX / S&P 25.82% / 15.00% |
WinTMDX / S&P 98.97% / 50.40% |
| 2026-Q12/3 |
LoseTMDX / S&P -18.28% / -4.33% |
WinTMDX / S&P 30.24% / 11.30% |
WinTMDX / S&P 218.98% / 27.70% |
| 2025-Q43/3 |
WinTMDX / S&P 8.42% / 2.65% |
WinTMDX / S&P 37.13% / 9.00% |
WinTMDX / S&P 377.45% / 13.40% |
| 2025-Q32/3 |
LoseTMDX / S&P -16.27% / 8.12% |
WinTMDX / S&P 41.20% / 4.61% |
WinTMDX / S&P 163.83% / 13.45% |
| 2025-Q23/3 |
WinTMDX / S&P 99.18% / 10.94% |
WinTMDX / S&P 48.09% / 4.83% |
WinTMDX / S&P 4750.00% / 10.63% |
| 2025-Q12/3 |
WinTMDX / S&P 7.91% / -4.27% |
WinTMDX / S&P 64.43% / 4.98% |
LoseTMDX / S&P -502.94% / 10.57% |
| 2024-Q41/3 |
LoseTMDX / S&P -60.29% / 2.41% |
WinTMDX / S&P 82.74% / 5.25% |
LoseTMDX / S&P -232.47% / 6.15% |
| 2024-Q31/3 |
LoseTMDX / S&P 4.24% / 5.89% |
WinTMDX / S&P 107.60% / 5.89% |
LoseTMDX / S&P -186.24% / 6.11% |
| 2024-Q22/3 |
WinTMDX / S&P 103.71% / 4.28% |
WinTMDX / S&P 137.47% / 5.38% |
LoseTMDX / S&P -107.14% / 5.12% |
| 2024-Q11/3 |
LoseTMDX / S&P -6.32% / 10.56% |
WinTMDX / S&P 149.23% / 5.71% |
LoseTMDX / S&P -63.83% / 5.59% |
| 2023-Q42/3 |
WinTMDX / S&P 44.16% / 11.69% |
WinTMDX / S&P 158.53% / 6.81% |
LoseTMDX / S&P -37.90% / 7.78% |
| 2023-Q31/3 |
LoseTMDX / S&P -34.81% / -3.27% |
WinTMDX / S&P 174.55% / 7.52% |
LoseTMDX / S&P -27.33% / -5.03% |
| 2023-Q22/3 |
WinTMDX / S&P 10.89% / 8.74% |
WinTMDX / S&P 193.46% / 9.50% |
LoseTMDX / S&P -67.44% / -8.57% |
| 2023-Q12/3 |
WinTMDX / S&P 22.70% / 7.50% |
WinTMDX / S&P 200.63% / 10.77% |
LoseTMDX / S&P -44.71% / -15.69% |
| 2022-Q42/3 |
WinTMDX / S&P 47.87% / 7.56% |
WinTMDX / S&P 197.78% / 11.88% |
LoseTMDX / S&P -22.98% / -17.99% |
| 2022-Q33/3 |
WinTMDX / S&P 32.72% / -4.88% |
WinTMDX / S&P 135.09% / 13.47% |
WinTMDX / S&P 9.49% / -1.41% |
| 2022-Q23/3 |
WinTMDX / S&P 16.74% / -16.10% |
WinTMDX / S&P 58.44% / 13.71% |
WinTMDX / S&P 57.80% / 11.04% |
| 2022-Q13/3 |
WinTMDX / S&P 40.61% / -4.60% |
WinTMDX / S&P 42.80% / 15.97% |
WinTMDX / S&P 60.38% / 42.23% |
| 2021-Q40/3 |
LoseTMDX / S&P -42.10% / 11.03% |
LoseTMDX / S&P 10.68% / 15.00% |
LoseTMDX / S&P 35.29% / 96.40% |
| 2021-Q31/3 |
LoseTMDX / S&P -0.27% / 0.58% |
WinTMDX / S&P 12.53% / 10.77% |
LoseTMDX / S&P TMDX unavailable / 69.42% |
| 2021-Q21/3 |
LoseTMDX / S&P -20.03% / 8.55% |
WinTMDX / S&P 22.60% / 6.58% |
LoseTMDX / S&P TMDX unavailable / 51.81% |
| 2021-Q11/3 |
WinTMDX / S&P 108.49% / 6.17% |
LoseTMDX / S&P -3.64% / -1.06% |
LoseTMDX / S&P TMDX unavailable / 7.39% |
| 2020-Q42/3 |
WinTMDX / S&P 44.41% / 12.15% |
WinTMDX / S&P 9.72% / -3.72% |
LoseTMDX / S&P TMDX unavailable / -33.42% |
| 2020-Q30/3 |
LoseTMDX / S&P -23.10% / 8.93% |
LoseTMDX / S&P TMDX unavailable / -2.04% |
LoseTMDX / S&P TMDX unavailable / -27.10% |
| 2020-Q21/3 |
WinTMDX / S&P 48.34% / 20.54% |
LoseTMDX / S&P TMDX unavailable / -0.46% |
LoseTMDX / S&P TMDX unavailable / -27.11% |
| 2020-Q10/3 |
LoseTMDX / S&P -36.45% / -19.60% |
LoseTMDX / S&P TMDX unavailable / 3.47% |
LoseTMDX / S&P TMDX unavailable / -14.75% |
| 2019-Q40/3 |
LoseTMDX / S&P -19.96% / 9.07% |
LoseTMDX / S&P TMDX unavailable / 5.36% |
LoseTMDX / S&P TMDX unavailable / 2.99% |
| 2019-Q30/3 |
LoseTMDX / S&P -18.08% / 1.70% |
LoseTMDX / S&P TMDX unavailable / 5.02% |
LoseTMDX / S&P TMDX unavailable / 0.21% |
| 2019-Q20/3 |
LoseTMDX / S&P TMDX unavailable / 4.30% |
LoseTMDX / S&P TMDX unavailable / 6.64% |
LoseTMDX / S&P TMDX unavailable / 8.65% |
| 2019-Q10/3 |
LoseTMDX / S&P TMDX unavailable / 13.65% |
LoseTMDX / S&P TMDX unavailable / 8.12% |
LoseTMDX / S&P TMDX unavailable / 14.29% |
| 2018-Q40/3 |
LoseTMDX / S&P TMDX unavailable / -13.52% |
LoseTMDX / S&P TMDX unavailable / 9.05% |
LoseTMDX / S&P TMDX unavailable / 18.23% |
| 2018-Q30/3 |
LoseTMDX / S&P TMDX unavailable / 7.71% |
LoseTMDX / S&P TMDX unavailable / 10.21% |
LoseTMDX / S&P TMDX unavailable / 19.06% |
| 2018-Q20/3 |
LoseTMDX / S&P TMDX unavailable / 3.43% |
LoseTMDX / S&P TMDX unavailable / 9.03% |
LoseTMDX / S&P TMDX unavailable / 14.46% |
| 2018-Q10/3 |
LoseTMDX / S&P TMDX unavailable / -0.76% |
LoseTMDX / S&P TMDX unavailable / 7.68% |
LoseTMDX / S&P TMDX unavailable / 12.46% |
| 2017-Q40/3 |
LoseTMDX / S&P TMDX unavailable / 6.64% |
LoseTMDX / S&P TMDX unavailable / 7.03% |
LoseTMDX / S&P TMDX unavailable / 13.82% |
| 2017-Q30/3 |
LoseTMDX / S&P TMDX unavailable / 4.48% |
LoseTMDX / S&P TMDX unavailable / 5.68% |
LoseTMDX / S&P TMDX unavailable / 17.57% |
| 2017-Q20/3 |
LoseTMDX / S&P TMDX unavailable / 3.09% |
LoseTMDX / S&P TMDX unavailable / 4.83% |
LoseTMDX / S&P TMDX unavailable / 17.74% |
| 2017-Q10/3 |
LoseTMDX / S&P TMDX unavailable / 6.07% |
LoseTMDX / S&P TMDX unavailable / 3.67% |
LoseTMDX / S&P TMDX unavailable / 13.32% |
| 2016-Q40/3 |
LoseTMDX / S&P TMDX unavailable / 3.82% |
LoseTMDX / S&P TMDX unavailable / 2.09% |
LoseTMDX / S&P TMDX unavailable / 7.05% |
| 2016-Q30/3 |
LoseTMDX / S&P TMDX unavailable / 3.85% |
LoseTMDX / S&P TMDX unavailable / 0.20% |
LoseTMDX / S&P TMDX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TMDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -20.19% | 20.78% |
| Annualized return | -20.19% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TMDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 185.74% | 83.14% |
| Annualized return | 23.37% | 12.86% |
10Y · 2019-05-02 to 2026-08-27
| Metric | TMDX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 310.33% | 319.30% |
| Annualized return | 15.16% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |